• Je něco špatně v tomto záznamu ?

International quality assurance of human papillomavirus testing

Lena Dillner, Joakim Dillner

. 2008 ; 16 (Suppl.) : S18-S20.

Jazyk angličtina Země Česko

Perzistentní odkaz   https://www.medvik.cz/link/bmc11039784

To contribute to improving quality of laboratory services for effective surveillance and monitoring of HPV vaccination impact, WHO has initiated a global HPV LabNet. The LabNet tasks are to facilitate implementation of standardized, state-of-the-art HPV laboratory methods by introducing international standards, proficiency testing reagents/methods, standard operating procedures and quality assurance (QA) programs in order to make results comparable across laboratories worldwide. The LabNet is also intended to form the basis for development of a global network for HPV surveillance by using standardized and harmonized laboratory methodologies in order to provide sound data to policy-makers. The LabNet is composed of 2 global reference laboratories (GRL) and 1-2 regional reference laboratories (RRL) in each WHO region. The GRL provide coordination of the network, lead development of QA programs and perform confirmatory testing of samples from regions. The GRL also oversee the HPV prevalences and vaccination impact worldwide through collaboration with RRL. Eventually, a formalized global HPV laboratory network will provide HPV surveillance and vaccination impact evaluation in an internationally harmonized way. Effective HPV surveillance programs will be an essential component of appropriately implemented HPV vaccination programs. Such surveillance should be based on internationally standardised and quality assured laboratory methods in order to make results comparable across laboratories in the world.

HPV in Human Pathology. Prague, Czech Republic, May 1-3, 2008

Bibliografie atd.

Lit.: 2

000      
00000naa 2200000 a 4500
001      
bmc11039784
003      
CZ-PrNML
005      
20150319090445.0
008      
111111s2008 xr e eng||
009      
AR
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Dillner, Lena
245    10
$a International quality assurance of human papillomavirus testing / $c Lena Dillner, Joakim Dillner
314    __
$a WHO HPV LabNet Global Reference Laboratory, Malmö
500    __
$a HPV in Human Pathology. Prague, Czech Republic, May 1-3, 2008
504    __
$a Lit.: 2
520    9_
$a To contribute to improving quality of laboratory services for effective surveillance and monitoring of HPV vaccination impact, WHO has initiated a global HPV LabNet. The LabNet tasks are to facilitate implementation of standardized, state-of-the-art HPV laboratory methods by introducing international standards, proficiency testing reagents/methods, standard operating procedures and quality assurance (QA) programs in order to make results comparable across laboratories worldwide. The LabNet is also intended to form the basis for development of a global network for HPV surveillance by using standardized and harmonized laboratory methodologies in order to provide sound data to policy-makers. The LabNet is composed of 2 global reference laboratories (GRL) and 1-2 regional reference laboratories (RRL) in each WHO region. The GRL provide coordination of the network, lead development of QA programs and perform confirmatory testing of samples from regions. The GRL also oversee the HPV prevalences and vaccination impact worldwide through collaboration with RRL. Eventually, a formalized global HPV laboratory network will provide HPV surveillance and vaccination impact evaluation in an internationally harmonized way. Effective HPV surveillance programs will be an essential component of appropriately implemented HPV vaccination programs. Such surveillance should be based on internationally standardised and quality assured laboratory methods in order to make results comparable across laboratories in the world.
650    _2
$a infekce papilomavirem $x diagnóza $x imunologie $7 D030361
650    _2
$a klinické laboratorní techniky $x metody $x přístrojové vybavení $x využití $7 D019411
650    _2
$a referenční standardy $7 D012015
650    _2
$a řízení kvality $7 D011786
650    _2
$a vakcíny proti papilomavirům $7 D053918
650    _2
$a plošný screening $x metody $x normy $x využití $7 D008403
650    _2
$a sérologie $x metody $x normy $7 D012699
650    _2
$a diagnostické techniky molekulární $x normy $x využití $7 D025202
650    _2
$a Světová zdravotnická organizace $7 D014944
650    _2
$a směrnice jako téma $7 D017408
650    _2
$a lidé $7 D006801
700    1_
$a Dillner, Joakim
773    0_
$w MED00001083 $t Central European journal of public health $g Roč. 16,Suppl. (2008), s. S18-S20 $x 1210-7778
773    0_
$t Central European journal of public health $g Roč. 16,Suppl. (2008), s. S18-S20 $w MED00001083
856    41
$u https://cejph.szu.cz/pdfs/cjp/2008/88/08.pdf $y plný text volně přístupný
910    __
$a ABA008 $b B 1829 $c 562 $y 2 $z 0
990    __
$a 20111109144052 $b ABA008
991    __
$a 20150319090729 $b ABA008
999    __
$a ok $b bmc $g 885962 $s 750167
BAS    __
$a 3
BMC    __
$a 2008 $b 16 $c Suppl. $d S18-S20 $m Central European Journal of Public Health $x MED00001083
BMC    __
$a 2008 $b 16 $c Suppl. $d S18-S20 $m HPV in human pathology $x MED00170653
LZP    __
$a 2011-CEJPH

Najít záznam